At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02652 CF PHARMTECH
Closed 08-14 16:08:36
16.900
-0.620
-3.54%
High17.700Low16.030Vol5.34M
Open17.150D1 Closing17.520Amplitude9.53%
Mkt Cap7.30BTradable Cap5.46BTotal Shares432.00M
T/O91.35MT/O Rate1.65%Tradable Shares323.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
CF Pharmtech Hits 10-Month Low, Raised HKD 295 Million in Quick Placement Amid R&D Spending and Valuation Correction
Deep News  ·  08-13 13:11
CF Pharmtech Hits 10-Month Low, Raised HKD 295 Million in Quick Placement Amid R&D Spending and Valuation Correction
Hong Kong Stocks Midday Summary: Hang Seng Index Edges Up 0.07% as Healthcare Sector Leads Gains
Stock News  ·  08-13 12:07
Hong Kong Stocks Midday Summary: Hang Seng Index Edges Up 0.07% as Healthcare Sector Leads Gains
CF Pharmtech Rises Over 5% at Midday After Completing Placement of 21.7 Million New H Shares
Deep News  ·  08-13 12:00
CF Pharmtech Rises Over 5% at Midday After Completing Placement of 21.7 Million New H Shares
CF PHARMTECH Shares Surge Over 5% Following Completion of H-Share Placement, ICF001 Poised to Fill Clinical Gap in PH-ILD Treatment
Stock News  ·  08-13 11:14
CF PHARMTECH Shares Surge Over 5% Following Completion of H-Share Placement, ICF001 Poised to Fill Clinical Gap in PH-ILD Treatment
CF PharmTech Completes Placement of 21,747,700 New H Shares at HK$ 13.82 Each
Reuters  ·  08-06
CF PharmTech Completes Placement of 21,747,700 New H Shares at HK$ 13.82 Each
CF PharmTech Maintains 411.98 Million Registered Shares and Confirms Ample Public Float in July 2026 Return
Bulletin Express  ·  08-04
CF PharmTech Maintains 411.98 Million Registered Shares and Confirms Ample Public Float in July 2026 Return
CF PharmTech to Raise HK$300.55 Million Through 7.23% H-Share Placement at 12% Discount
Bulletin Express  ·  07-31
CF PharmTech to Raise HK$300.55 Million Through 7.23% H-Share Placement at 12% Discount
CF PHARMTECH Plans to Place 21.75 Million New H-Shares, Raising Approximately HKD 295 Million
Stock News  ·  07-31
CF PHARMTECH Plans to Place 21.75 Million New H-Shares, Raising Approximately HKD 295 Million
CF Pharmtech - to Place 21.7 Mln New H Shares at Hk$13.82 Per Share
THOMSON REUTERS  ·  07-31
CF Pharmtech - to Place 21.7 Mln New H Shares at Hk$13.82 Per Share
CF PharmTech Prices HK$ 300.55 Million H-share Placement at HK$ 13.82 Each
Reuters  ·  07-31
CF PharmTech Prices HK$ 300.55 Million H-share Placement at HK$ 13.82 Each
CF PharmTech Updates Board Composition and Committee Leadership
Bulletin Express  ·  06-26
CF PharmTech Updates Board Composition and Committee Leadership
CF Pharmtech Elects New Board, Names Zhang Jingjing Executive Director
Reuters  ·  06-26
CF Pharmtech Elects New Board, Names Zhang Jingjing Executive Director
CF PHARMTECH Announces Adjustment to H Share Trading Board Lot Size
Stock News  ·  06-22
CF PHARMTECH Announces Adjustment to H Share Trading Board Lot Size
CF PHARMTECH (02652) Repurchases 9,000 Shares for HK$164,000 on June 15
Stock News  ·  06-15
CF PHARMTECH (02652) Repurchases 9,000 Shares for HK$164,000 on June 15
CF Pharmtech files HKEX next-day disclosure return reporting share repurchase at HKD 18.26
Reuters  ·  06-15
CF Pharmtech files HKEX next-day disclosure return reporting share repurchase at HKD 18.26
CF PharmTech executes HKD 0.25 million buyback, trims free float by 0.0047%
Bulletin Express  ·  06-12
CF PharmTech executes HKD 0.25 million buyback, trims free float by 0.0047%
CF PHARMTECH (02652) Allocates HK$968.9k for Share Buyback on June 11
Stock News  ·  06-11
CF PHARMTECH (02652) Allocates HK$968.9k for Share Buyback on June 11
CF Pharmtech files HKEX next-day disclosure return on share buyback at HKD 18.28 average price
Reuters  ·  06-11
CF Pharmtech files HKEX next-day disclosure return on share buyback at HKD 18.28 average price
CF PharmTech repurchases 14,500 H-shares; outstanding share count dips 0.0048%
Bulletin Express  ·  06-10
CF PharmTech repurchases 14,500 H-shares; outstanding share count dips 0.0048%
CF PharmTech executes HKD 0.59 million share buyback; outstanding share count trimmed by 0.01%
Bulletin Express  ·  06-09
CF PharmTech executes HKD 0.59 million share buyback; outstanding share count trimmed by 0.01%

Introduction

Company Name.
CF PHARMTECH
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
CF PharmTech, Inc. is a China-based company primarily the research and development, production and sale of respiratory drugs and other related medical products. The Company’s product portfolio primarily focused on respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD) and allergic rhinitis. The Company's primary products include CF017, a budesonide suspension for inhalation targeting bronchial asthma, and CF018, an azelastine hydrochloride and fluticasone propionate nasal spray approved for allergic rhinitis. The Company mainly conducts its business in the domestic market.
Issue price:
--